Comparative Study of Alternative Antiandrogen (AA) Therapy and Early Initiating of Enzalutamide for Castration-resistant Prostate Cancer (CRPC) After Combined Androgen Blockade (CAB) Therapy.
Clinical trial NCT02346578 · COMPLETED
Trial details
- NCT number
- NCT02346578
- Sponsor
- Taro Iguchi, MD, PHD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2018-09-30
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.